Udbhav Ram.
List
Research2020 · Co-authored journal article · Molecular Nutrition & Food Research

An early question about membranes.

Original schematic of four dietary compounds studied with amyloid beta in a synthetic brain membrane model
Original explanatory schematic of the published membrane model · Not a paper figure · Source

Before the clinical-AI projects, biophysics offered a way to study complex biological questions through a controlled model system. This paper investigates interactions between selected compounds, synthetic membranes, and amyloid aggregates.

Dietary compounds and amyloid aggregation in synthetic brain membranes
All research

A model system for a molecular question

The study investigated resveratrol, caffeine, beta-carotene, and epigallocatechin gallate (EGCG) in synthetic brain membranes with amyloid-β25–35.

Different compounds affected membrane properties and aggregation in different ways. The work explored a membrane-mediated mechanism in a biophysical model system.

Scope of the evidence

Synthetic membranes make it possible to isolate aspects of a complex biological process. They are not a substitute for the physiology of a person.

This is not a clinical trial, and the paper does not establish that these compounds prevent or treat Alzheimer’s disease.

The published record

The article by Isabella P. Gastaldo, Sebastian Himbert, Udbhav Ram, and Maikel C. Rheinstädter was first published on September 27, 2020, in Molecular Nutrition & Food Research, volume 64, issue 22, article e2000632.

Sources & further reading

Research summary updated October 5, 2026. Findings describe the linked study and do not establish clinical readiness beyond its evaluation.

Connected evidence

Keep exploring.